Loading resource…

University of Michigan, Ann Arbor, Michigan, USA
Systemic lupus erythematosus (SLE) is a devastating autoimmune disease that can result in substantial morbidity and mortality. Diagnosis and treatment of SLE are clinical challenges due to the heterogeneous patient presentation and response to therapy. The document discusses the intricate interplay between genetic risk and immune system responses that lead to SLE pathogenesis, as well as the need for effective management strategies that consider precision therapies and social determinants of health.
No account needed